<bill session="117" type="h" number="5745" updated="2022-12-30T07:34:00Z">
  <state datetime="2021-10-27">REFERRED</state>
  <status>
    <introduced datetime="2021-10-27"/>
  </status>
  <introduced datetime="2021-10-27"/>
  <titles>
    <title type="display">COVID&#226;&#8364;&#8220;19 Access to Testing and Support for Immune Response Research Act of 2021</title>
    <title type="short" as="introduced">COVID&#226;&#8364;&#8220;19 Access to Testing and Support for Immune Response Research Act of 2021</title>
    <title type="official" as="introduced">To clarify Medicare coverage for COVID-19 testing and to provide support for cellular immune response research for COVID-19, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000628"/>
  <cosponsors>
    <cosponsor bioguide_id="B001257" joined="2022-01-19"/>
    <cosponsor bioguide_id="J000304" joined="2021-10-27"/>
  </cosponsors>
  <actions>
    <action datetime="2021-10-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-10-27" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-10-27">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-10-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-10-28">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Aging"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Cell biology and embryology"/>
    <term name="Child health"/>
    <term name="Department of Health and Human Services"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-08T23:04:54Z" status="Introduced in House">COVID-19 Access to Testing and Support for Immune Response Research Act of 2021

This bill requires the Centers for Medicare &amp; Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.</summary>
</bill>
